Hypertension, antihypertensive medication use, and breast cancer risk in the California teachers study cohort

Cancer Causes and Control

Volumn 21, Issue 10, 2010, Pages 1615-1624

  Largent, Joan A ^a   Bernstein, Leslie ^b,e   Horn Ross, Pamela L ^c,d   Marshall, Sarah F ^a   Neuhausen, Susan ^b   Reynolds, Peggy ^c,d   Ursin, Giske ^e,f   Zell, Jason A ^a   Ziogas, Argyrios ^a   Anton Culver, Hoda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c NORTHERN CALIFORNIA CANCER CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

Antihypertensive medication; Breast cancer; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTROGEN RECEPTOR; FUROSEMIDE; RESERPINE; THIAZIDE DIURETIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; BREAST FEEDING; CALORIC INTAKE; CANCER INVASION; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; ETHNICITY; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSE; NULLIPARA; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; UNITED STATES;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BREAST NEOPLASMS; CALIFORNIA; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MENOPAUSE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 77956957202     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9590-x     Document Type: Article

References (35)

1. Horner MJ RL, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds) (2009) SEER Cancer Statistics Review, 1975-2006. In: based on November 2008 SEER data submission. National Cancer Institute, Bethesda
2. Surveillance E, End Results (SEER) Program ( www.seer.cancer.gov ) SEERStat Databasev (2008) Mortality-All COD, Public-Use with State, Total U.S. (1969-2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released February 2008
3. VL Burt P Whelton EJ Roccella C Brown JA Cutler M Higgins MJ Horan D Labarthe 1995 Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991 Hypertension 25 3 305 313 1:STN:280:DyaK2M7otV2gsA%3D%3D 7875754
4. G Corrao L Scotti V Bagnardi R Sega 2007 Hypertension, antihypertensive therapy and renal-cell cancer: a meta-analysis Curr Drug Saf 2 2 125 133 10.2174/157488607780598296 18690958
5. AS Furberg I Thune 2003 Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort Int J Cancer 104 6 669 676 1:CAS:528:DC%2BD3sXjtVWqsb0%3D 10.1002/ijc.10974 12640672
6. R Boynton-Jarrett J Rich-Edwards S Malspeis SA Missmer R Wright 2005 A prospective study of hypertension and risk of uterine leiomyomata Am J Epidemiol 161 7 628 638 10.1093/aje/kwi072 15781952
7. AM Lindgren AM Nissinen JO Tuomilehto E Pukkala 2005 Cancer pattern among hypertensive patients in North Karelia, Finland J Hum Hypertens 19 5 373 379 1:STN:280:DC%2BD2M3gtlOktw%3D%3D 10.1038/sj.jhh.1001834 15703772
8. M Soler L Chatenoud E Negri F Parazzini S Franceschi C la Vecchia 1999 Hypertension and hormone-related neoplasms in women Hypertension 34 2 320 325 1:STN:280:DyaK1MzosVSntg%3D%3D 10454461
9. PK Goon FH Messerli GY Lip 2006 Hypertension and breast cancer: an association revisited? J Hum Hypertens 20 10 722 724 1:STN:280: DC%2BD28rmt1GitQ%3D%3D 10.1038/sj.jhh.1002053 16885997
10. EB Schwarz RM Ray AM Stuebe MA Allison RB Ness MS Freiberg JA Cauley 2009 Duration of lactation and risk factors for maternal cardiovascular disease Obstet Gynecol 113 5 974 982 19384111
11. L Vona-Davis M Howard-McNatt DP Rose 2007 Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer Obes Rev 8 5 395 408 1:STN:280:DC%2BD2svpslCqug%3D%3D 10.1111/j.1467-789X.2007.00396.x 17716297
12. D Xing S Nozell YF Chen F Hage S Oparil 2009 Estrogen and mechanisms of vascular protection Arterioscler Thromb Vasc Biol 29 3 289 295 1:CAS:528:DC%2BD1MXhs1Cgt7s%3D 10.1161/ATVBAHA.108.182279 19221203
13. P Hamet 1997 Cancer and hypertension: a potential for crosstalk? J Hypertens 15 12 Pt 2 1573 1577 1:CAS:528:DyaK1cXoslaruw%3D%3D 10.1097/00004872-199715120-00058 9488208
14. SH Giordano 2003 Breast carcinoma and antihypertensive therapy Cancer 98 7 1334 1336 10.1002/cncr.11695 14508818
15. L Bernstein M Allen H Anton-Culver D Deapen PL Horn-Ross D Peel R Pinder P Reynolds J Sullivan-Halley D West, et al. 2002 High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States) Cancer Causes Control 13 7 625 635 10.1023/A:1019552126105 12296510
16. Kelsey JL, Whittemore AS, Evans AS (1986) Methods in observational epidemiology. Oxford University Press, Oxford
17. E Weiderpass I Persson HO Adami C Magnusson A Lindgren JA Baron 2000 Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden) Cancer Causes Control 11 2 185 192 1:STN:280:DC%2BD3c7ntlCgug%3D%3D 10.1023/A:1008946825313 10710204
18. PH Peeters PA van Noord AW Hoes J Fracheboud CH Gimbrere DE Grobbee 2000 Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer J Hypertens 18 3 249 254 1:STN:280:DC%2BD3c7ovFansQ%3D%3D 10.1097/00004872-200018030-00002 10726709
19. JA Largent AJ McEligot A Ziogas C Reid J Hess N Leighton D Peel H Anton-Culver 2006 Hypertension, diuretics and breast cancer risk J Hum Hypertens 20 10 727 732 1:STN:280:DC%2BD28rmt1GitA%3D%3D 10.1038/sj.jhh.1002075 16885996
20. NK Beji N Reis 2007 Risk factors for breast cancer in Turkish women: a hospital-based case-control study Eur J Cancer Care (Engl) 16 2 178 184 1:STN:280:DC%2BD2s7ntlelug%3D%3D 10.1111/j.1365-2354.2006.00711.x
21. A Lindgren E Pukkala J Tuomilehto A Nissinen 2007 Incidence of breast cancer among postmenopausal, hypertensive women Int J Cancer 121 3 641 644 1:CAS:528:DC%2BD2sXnt1Crsrw%3D 10.1002/ijc.22689 17372911
22. GC Kabat M Kim RT Chlebowski J Khandekar MG Ko A McTiernan ML Neuhouser DR Parker JM Shikany ML Stefanick, et al. 2009 A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer Cancer Epidemiol Biomarkers Prev 18 7 2046 2053 1:CAS:528:DC%2BD1MXosFWjsrs%3D 10.1158/1055-9965.EPI-09-0235 19567502
23. E Grossman FH Messerli U Goldbourt 2001 Antihypertensive therapy and the risk of malignancies Eur Heart J 22 15 1343 1352 1:CAS:528:DC%2BD3MXmsVygsLg%3D 10.1053/euhj.2001.2729 11465967
24. CI Li KE Malone NS Weiss DM Boudreau KL Cushing-Haugen JR Daling 2003 Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years Cancer 98 7 1504 1513 10.1002/cncr.11663 14508839
25. PF Coogan BL Strom L Rosenberg 2009 Diuretic use and the risk of breast cancer J Hum Hypertens 23 3 216 218 1:STN:280:DC%2BD1M7jslalsg%3D%3D 10.1038/jhh.2008.131 18971940
26. JP Fryzek AH Poulsen L Lipworth L Pedersen M Norgaard JK McLaughlin S Friis 2006 A cohort study of antihypertensive medication use and breast cancer among Danish women Breast Cancer Res Treat 97 3 231 236 10.1007/s10549-005-9091- x 16791484
27. A Gonzalez-Perez G Ronquist LA Garcia Rodriguez 2004 Breast cancer incidence and use of antihypertensive medication in women Pharmacoepidemiol Drug Saf 13 8 581 585 10.1002/pds.910 15317040
28. P Hamet L Richard TV Dam E Teiger SN Orlov L Gaboury F Gossard J Tremblay 1995 Apoptosis in target organs of hypertension Hypertension 26 4 642 648 1:STN:280:DyaK28%2FjsF2ntg%3D%3D 7558225
29. A Aviv H Aviv 1997 Reflections on telomeres, growth, aging, and essential hypertension Hypertension 29 5 1067 1072 1:STN:280:DyaK2s3ptlOksQ%3D%3D 9149667
30. DC Sane L Anton KB Brosnihan 2004 Angiogenic growth factors and hypertension Angiogenesis 7 3 193 201 1:CAS:528:DC%2BD2MXht1KjsbY%3D 10.1007/s10456-004-2699-3 15609074
31. KJ Hunt A Lukanova S Rinaldi E Lundin T Norat R Palmqvist P Stattin E Riboli G Hallmans R Kaaks 2006 A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study Ann Epidemiol 16 7 563 571 10.1016/j.annepidem.2005.10.007 16431135
32. D Lithgow C Covington 2005 Chronic inflammation and breast pathology: a theoretical model Biol Res Nurs 7 2 118 129 10.1177/1099800405280823 16267373
33. Ostchega Y, Yoon SS, Hughes J, Louis T (2008) Hypertension awareness, treatment, and control-continued disparities in adults: United States, 2005-2006. In: NCHS data brief. National Center for Health Statistics, Hyattsville
34. DM Boudreau JR Daling KE Malone JS Gardner DK Blough SR Heckbert 2004 A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women Am J Epidemiol 159 3 308 317 10.1093/aje/kwh038 14742292
35. Kwong S PC, Morris C, Cohen R, Allen M, Wright W (2001) Cancer in California: 1988-1999. In: Sacramento: California Department of Health Services, Cancer Surveillance Section